These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 29115427)

  • 1. Abnormal DNA methylation may contribute to the progression of osteosarcoma.
    Chen XG; Ma L; Xu JX
    Mol Med Rep; 2018 Jan; 17(1):193-199. PubMed ID: 29115427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of miR‑542‑3p in osteosarcoma with miRNA microarray data, and its potential signaling pathways.
    Li Z; Yao JN; Huang WT; He RQ; Ma J; Chen G; Wei QJ
    Mol Med Rep; 2019 Feb; 19(2):974-983. PubMed ID: 30569116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
    Li H; Liu JW; Liu S; Yuan Y; Sun LP
    Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG methylation patterns are associated with gene expression variation in osteosarcoma.
    Wang Q
    Mol Med Rep; 2017 Jul; 16(1):901-907. PubMed ID: 28560411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory network of differentially expressed genes in metastatic osteosarcoma.
    Yao P; Wang ZB; Ding YY; Ma JM; Hong T; Pan SN; Zhang J
    Mol Med Rep; 2015 Mar; 11(3):2104-10. PubMed ID: 25434727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of crucial genes and microRNAs in conventional osteosarcoma using gene expression profiling analysis.
    Peng C; Yang Q; Wei B; Yuan B; Liu Y; Li Y; Gu D; Yin G; Wang B; Xu D; Zhang X; Kong D
    Mol Med Rep; 2017 Nov; 16(5):7617-7624. PubMed ID: 28944822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
    Yi L; Luo P; Zhang J
    J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating age‑induced differentially expressed genes and potential molecular mechanisms in osteosarcoma based on integrated bioinformatics analysis.
    Wang JS; Duan MY; Zhong YS; Li XD; Du SX; Xie P; Zheng GZ; Han JM
    Mol Med Rep; 2019 Apr; 19(4):2729-2739. PubMed ID: 30720085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the key genes and pathways of osteosarcoma with pulmonary metastasis using a gene expression microarray.
    Shi Z; Zhou H; Pan B; Lu L; Wei Z; Shi L; Yao X; Kang Y; Feng S
    Mol Med Rep; 2017 Nov; 16(5):7423-7431. PubMed ID: 28944885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling analysis of osteosarcoma cell lines.
    Sun L; Li J; Yan B
    Mol Med Rep; 2015 Sep; 12(3):4266-4272. PubMed ID: 26096802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive bioinformation analysis of methylated and differentially expressed genes in esophageal squamous cell carcinoma.
    Peng H; Wang S; Pang L; Yang L; Chen Y; Cui XB
    Mol Omics; 2019 Feb; 15(1):88-100. PubMed ID: 30706927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A support vector machine classifier for the prediction of osteosarcoma metastasis with high accuracy.
    He Y; Ma J; Ye X
    Int J Mol Med; 2017 Nov; 40(5):1357-1364. PubMed ID: 28901446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential crucial genes and key pathways in osteosarcoma.
    Liu J; Wu S; Xie X; Wang Z; Lei Q
    Hereditas; 2020 Jul; 157(1):29. PubMed ID: 32665038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of gene expression and genomic aberration data in osteosarcoma (OS).
    Xiong Y; Wu S; Du Q; Wang A; Wang Z
    Cancer Gene Ther; 2015 Nov; 22(11):524-9. PubMed ID: 26427513
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Li S; Wu X; Pei Y; Wang W; Zheng K; Qiu E; Zhang X
    DNA Cell Biol; 2019 Nov; 38(11):1323-1337. PubMed ID: 31536386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
    Sang L; Wang XM; Xu DY; Zhao WJ
    World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of key biomarkers involved in osteosarcoma using altered modules.
    Liu ZZ; Cui ST; Tang B; Wang ZZ; Luan ZX
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of methylated genes and miRNA signatures in nasopharyngeal carcinoma by bioinformatics analysis.
    Wang Y; Zhao Q; Lan N; Wang S
    Mol Med Rep; 2018 Apr; 17(4):4909-4916. PubMed ID: 29393436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Logistic regression analysis for the identification of the metastasis-associated signaling pathways of osteosarcoma.
    Liu Y; Sun W; Ma X; Hao Y; Liu G; Hu X; Shang H; Wu P; Zhao Z; Liu W
    Int J Mol Med; 2018 Mar; 41(3):1233-1244. PubMed ID: 29328361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation biomarkers for nasopharyngeal carcinoma.
    Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
    PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.